Načítá se...
Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma
INTRODUCTION: A combination of pemetrexed and cisplatin has been shown to improve the outcome in patients with malignant pleural mesothelioma (MPM), however, there is a great heterogeneity in treatment response among patients. The aim of our study was to evaluate the influence of polymorphisms in fo...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Versita, Warsaw
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4078035/ https://ncbi.nlm.nih.gov/pubmed/24991206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2013-0086 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|